{"version":"1.0","type":"link","title":"Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.","author_name":"Borazanci EH 외","author_url":"https://prs-insight.online/author/Borazanci%20EH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/155694","thumbnail_width":1200,"thumbnail_height":630}